vs

Side-by-side financial comparison of Ametek (AME) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

Ametek is the larger business by last-quarter revenue ($2.0B vs $1.4B, roughly 1.5× PACS Group, Inc.). Ametek runs the higher net margin — 19.9% vs 4.4%, a 15.5% gap on every dollar of revenue. On growth, PACS Group, Inc. posted the faster year-over-year revenue change (18.4% vs 13.4%). Over the past eight quarters, PACS Group, Inc.'s revenue compounded faster (20.5% CAGR vs 7.3%).

AMETEK, Inc. is an American multinational conglomerate and global designer and manufacturer of electronic instruments and electromechanical devices with headquarters in the United States and over 150 sites worldwide.

AME vs PACS — Head-to-Head

Bigger by revenue
AME
AME
1.5× larger
AME
$2.0B
$1.4B
PACS
Growing faster (revenue YoY)
PACS
PACS
+5.0% gap
PACS
18.4%
13.4%
AME
Higher net margin
AME
AME
15.5% more per $
AME
19.9%
4.4%
PACS
Faster 2-yr revenue CAGR
PACS
PACS
Annualised
PACS
20.5%
7.3%
AME

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AME
AME
PACS
PACS
Revenue
$2.0B
$1.4B
Net Profit
$398.6M
$59.7M
Gross Margin
36.0%
Operating Margin
25.3%
7.0%
Net Margin
19.9%
4.4%
Revenue YoY
13.4%
18.4%
Net Profit YoY
2.9%
3022.5%
EPS (diluted)
$1.73
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AME
AME
PACS
PACS
Q4 25
$2.0B
$1.4B
Q3 25
$1.9B
$1.3B
Q2 25
$1.8B
$1.3B
Q1 25
$1.7B
$1.3B
Q4 24
$1.8B
$1.1B
Q3 24
$1.7B
$1.0B
Q2 24
$1.7B
$981.4M
Q1 24
$1.7B
$934.3M
Net Profit
AME
AME
PACS
PACS
Q4 25
$398.6M
$59.7M
Q3 25
$371.4M
$52.4M
Q2 25
$358.4M
$51.0M
Q1 25
$351.8M
$28.5M
Q4 24
$387.3M
$1.9M
Q3 24
$340.2M
$15.6M
Q2 24
$337.7M
$-10.9M
Q1 24
$310.9M
$49.1M
Gross Margin
AME
AME
PACS
PACS
Q4 25
36.0%
Q3 25
36.3%
Q2 25
35.8%
Q1 25
36.1%
Q4 24
36.6%
Q3 24
36.0%
17.1%
Q2 24
36.0%
22.3%
Q1 24
34.1%
21.2%
Operating Margin
AME
AME
PACS
PACS
Q4 25
25.3%
7.0%
Q3 25
25.8%
6.4%
Q2 25
26.0%
6.2%
Q1 25
26.3%
3.8%
Q4 24
26.6%
1.7%
Q3 24
26.1%
2.2%
Q2 24
25.8%
0.1%
Q1 24
24.0%
8.6%
Net Margin
AME
AME
PACS
PACS
Q4 25
19.9%
4.4%
Q3 25
19.6%
3.9%
Q2 25
20.2%
3.9%
Q1 25
20.3%
2.2%
Q4 24
22.0%
0.2%
Q3 24
19.9%
1.5%
Q2 24
19.5%
-1.1%
Q1 24
17.9%
5.3%
EPS (diluted)
AME
AME
PACS
PACS
Q4 25
$1.73
$0.42
Q3 25
$1.60
$0.32
Q2 25
$1.55
$0.31
Q1 25
$1.52
$0.17
Q4 24
$1.67
$-0.03
Q3 24
$1.47
$0.10
Q2 24
$1.45
$-0.07
Q1 24
$1.34
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AME
AME
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$458.0M
$197.0M
Total DebtLower is stronger
$2.3B
$353.2M
Stockholders' EquityBook value
$10.6B
$946.8M
Total Assets
$16.1B
$5.6B
Debt / EquityLower = less leverage
0.21×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AME
AME
PACS
PACS
Q4 25
$458.0M
$197.0M
Q3 25
$439.2M
$355.7M
Q2 25
$619.7M
$294.2M
Q1 25
$399.0M
$287.5M
Q4 24
$374.0M
$157.7M
Q3 24
$396.3M
$49.5M
Q2 24
$396.6M
$73.4M
Q1 24
$373.8M
$81.2M
Total Debt
AME
AME
PACS
PACS
Q4 25
$2.3B
$353.2M
Q3 25
Q2 25
Q1 25
Q4 24
$2.1B
$411.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AME
AME
PACS
PACS
Q4 25
$10.6B
$946.8M
Q3 25
$10.5B
$871.3M
Q2 25
$10.4B
$806.8M
Q1 25
$10.0B
$750.2M
Q4 24
$9.7B
$709.6M
Q3 24
$9.6B
$660.0M
Q2 24
$9.3B
$572.1M
Q1 24
$9.0B
$128.0M
Total Assets
AME
AME
PACS
PACS
Q4 25
$16.1B
$5.6B
Q3 25
$16.2B
$5.6B
Q2 25
$15.3B
$5.5B
Q1 25
$14.9B
$5.5B
Q4 24
$14.6B
$5.2B
Q3 24
$14.8B
$4.5B
Q2 24
$14.8B
$3.9B
Q1 24
$14.9B
$3.9B
Debt / Equity
AME
AME
PACS
PACS
Q4 25
0.21×
0.37×
Q3 25
Q2 25
Q1 25
Q4 24
0.22×
0.58×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AME
AME
PACS
PACS
Operating Cash FlowLast quarter
$584.3M
$-3.4M
Free Cash FlowOCF − Capex
$527.3M
FCF MarginFCF / Revenue
26.4%
Capex IntensityCapex / Revenue
2.9%
Cash ConversionOCF / Net Profit
1.47×
-0.06×
TTM Free Cash FlowTrailing 4 quarters
$1.7B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AME
AME
PACS
PACS
Q4 25
$584.3M
$-3.4M
Q3 25
$440.9M
$204.8M
Q2 25
$359.1M
$52.6M
Q1 25
$417.5M
$150.2M
Q4 24
$550.0M
$64.6M
Q3 24
$487.2M
$209.2M
Q2 24
$381.4M
$34.8M
Q1 24
$410.2M
$58.8M
Free Cash Flow
AME
AME
PACS
PACS
Q4 25
$527.3M
Q3 25
$420.0M
Q2 25
$329.8M
Q1 25
$394.5M
Q4 24
$498.3M
Q3 24
$460.9M
Q2 24
$360.0M
Q1 24
$382.6M
FCF Margin
AME
AME
PACS
PACS
Q4 25
26.4%
Q3 25
22.2%
Q2 25
18.5%
Q1 25
22.8%
Q4 24
28.3%
Q3 24
27.0%
Q2 24
20.8%
Q1 24
22.0%
Capex Intensity
AME
AME
PACS
PACS
Q4 25
2.9%
Q3 25
1.1%
Q2 25
1.6%
Q1 25
1.3%
Q4 24
2.9%
Q3 24
1.5%
Q2 24
1.2%
Q1 24
1.6%
Cash Conversion
AME
AME
PACS
PACS
Q4 25
1.47×
-0.06×
Q3 25
1.19×
3.91×
Q2 25
1.00×
1.03×
Q1 25
1.19×
5.28×
Q4 24
1.42×
33.78×
Q3 24
1.43×
13.39×
Q2 24
1.13×
Q1 24
1.32×
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AME
AME

Transferred At Point In Time$1.1B54%
Electronic Instruments Group$620.1M31%
Transferred Over Time$294.6M15%

PACS
PACS

Segment breakdown not available.

Related Comparisons